FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022791965> ?p ?o ?g. }

• W2022791965 endingPage "537" @default.
• W2022791965 startingPage "525" @default.
• W2022791965 abstract "Objectives To review the literature on the current use of vasopressors and inotropes in patients with sepsis and sepsis syndrome with respect to the choice of agent, therapeutic end points, and safe and effective doses to be used. To examine the available evidence that supports or refutes goal-directed therapy toward supranormal oxygen transport in optimizing the outcome of critically ill sepsis syndrome patients. Data Sources All pertinent English and French articles dealing with hemodynamic support with selected vasopressors and inotropic agents in human sepsis and sepsis syndrome retrieved from a computerized MEDLINE search from 1985 to 1994. Study Selection Clinical studies with norepinephrine, epinephrine, phenylephrine, dopamine, and dobutamine in sepsis syndrome were considered if goal-directed therapy with oxygen transport variables was utilized. Emphasis was placed on prospective, randomized, controlled comparative trials. However, openlabel, observational, and comparative studies, or case series, were also evaluated when limited data were available. Data Extraction From the selected studies, information was obtained regarding patient population, dosing regimen, type of therapeutic goals or end points (hemodynamic, or normal vs. supranormal oxygen transport variables) and outcome data (e.g., achievement of goals, resolution of the episode, mortality rate, and development of end-organ dysfunction). Data Synthesis When used in larger than usual doses, epinephrine, norepinephrine, and phenylephrine uniformly increased hemodynamic values. Epinephrine may increase oxygen transport values more reliably than norepinephrine. Dobutamine doses in the range of 2.5 to 6 micro gram/kg/min increase oxygen transport variables and hemodynamics to predetermined goals in only 30% to 70% of patients. Larger infusion rates offer no further benefits. Conclusions Insufficient evidence exists to support goal-directed therapy with vasopressors and inotropes in the treatment of sepsis syndrome. No definitive recommendations can be made about the superiority of a vasopressor or inotropic agent due to the lack of data. However, it may be that evaluation of vasopressors earlier in sepsis syndrome will yield more promising results. Large, comparative, controlled trials assessing mortality rate and development of multiple organ system dysfunction are needed. (Crit Care Med 1996; 24:525-537)" @default.
• W2022791965 created "2016-06-24" @default.
• W2022791965 creator A5024748503 @default.
• W2022791965 creator A5072065976 @default.
• W2022791965 creator A5084237031 @default.
• W2022791965 date "1996-03-01" @default.
• W2022791965 modified "2023-09-25" @default.
• W2022791965 title "Is it time to reposition vasopressors and inotropes in sepsis?" @default.
• W2022791965 cites W1208096063 @default.
• W2022791965 cites W1975344770 @default.
• W2022791965 cites W1975738422 @default.
• W2022791965 cites W1977478388 @default.
• W2022791965 cites W1979538938 @default.
• W2022791965 cites W1992442197 @default.
• W2022791965 cites W1996077728 @default.
• W2022791965 cites W1997093143 @default.
• W2022791965 cites W2000062813 @default.
• W2022791965 cites W2001043846 @default.
• W2022791965 cites W2002534139 @default.
• W2022791965 cites W2003373752 @default.
• W2022791965 cites W2004018819 @default.
• W2022791965 cites W2004179477 @default.
• W2022791965 cites W2005149785 @default.
• W2022791965 cites W2006919847 @default.
• W2022791965 cites W2010094172 @default.
• W2022791965 cites W2011077993 @default.
• W2022791965 cites W2021000405 @default.
• W2022791965 cites W2023378098 @default.
• W2022791965 cites W2023915714 @default.
• W2022791965 cites W2025891994 @default.
• W2022791965 cites W2026047073 @default.
• W2022791965 cites W2026173173 @default.
• W2022791965 cites W2028070168 @default.
• W2022791965 cites W2030136325 @default.
• W2022791965 cites W2036944903 @default.
• W2022791965 cites W2039602526 @default.
• W2022791965 cites W2039747192 @default.
• W2022791965 cites W2044445149 @default.
• W2022791965 cites W2046849702 @default.
• W2022791965 cites W2047078710 @default.
• W2022791965 cites W2049251799 @default.
• W2022791965 cites W2049678810 @default.
• W2022791965 cites W2059625790 @default.
• W2022791965 cites W2061386415 @default.
• W2022791965 cites W2065699321 @default.
• W2022791965 cites W2066769793 @default.
• W2022791965 cites W2067464272 @default.
• W2022791965 cites W2068752964 @default.
• W2022791965 cites W2069966919 @default.
• W2022791965 cites W2076486635 @default.
• W2022791965 cites W2076988944 @default.
• W2022791965 cites W2085963630 @default.
• W2022791965 cites W2086226482 @default.
• W2022791965 cites W2088348135 @default.
• W2022791965 cites W2088354042 @default.
• W2022791965 cites W2093357724 @default.
• W2022791965 cites W2093522677 @default.
• W2022791965 cites W2112875552 @default.
• W2022791965 cites W2128855592 @default.
• W2022791965 cites W2142778909 @default.
• W2022791965 cites W2143939329 @default.
• W2022791965 cites W2156967952 @default.
• W2022791965 cites W2177254638 @default.
• W2022791965 cites W2317923971 @default.
• W2022791965 cites W2402440776 @default.
• W2022791965 cites W2414367703 @default.
• W2022791965 cites W4300869359 @default.
• W2022791965 cites W4301360703 @default.
• W2022791965 cites W4321258388 @default.
• W2022791965 cites W76818083 @default.
• W2022791965 doi "https://doi.org/10.1097/00003246-199603000-00026" @default.
• W2022791965 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8625645" @default.
• W2022791965 hasPublicationYear "1996" @default.
• W2022791965 type Work @default.
• W2022791965 sameAs 2022791965 @default.
• W2022791965 citedByCount "105" @default.
• W2022791965 countsByYear W20227919652012 @default.
• W2022791965 countsByYear W20227919652013 @default.
• W2022791965 countsByYear W20227919652014 @default.
• W2022791965 countsByYear W20227919652015 @default.
• W2022791965 countsByYear W20227919652016 @default.
• W2022791965 countsByYear W20227919652019 @default.
• W2022791965 countsByYear W20227919652022 @default.
• W2022791965 crossrefType "journal-article" @default.
• W2022791965 hasAuthorship W2022791965A5024748503 @default.
• W2022791965 hasAuthorship W2022791965A5072065976 @default.
• W2022791965 hasAuthorship W2022791965A5084237031 @default.
• W2022791965 hasConcept C126322002 @default.
• W2022791965 hasConcept C155710745 @default.
• W2022791965 hasConcept C164705383 @default.
• W2022791965 hasConcept C168563851 @default.
• W2022791965 hasConcept C177713679 @default.
• W2022791965 hasConcept C178790620 @default.
• W2022791965 hasConcept C178853913 @default.
• W2022791965 hasConcept C185592680 @default.
• W2022791965 hasConcept C2775859304 @default.
• W2022791965 hasConcept C2778384902 @default.
• W2022791965 hasConcept C2778514916 @default.

• next